Product Information
CARVEDILOL 25 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0323 per EA under NDC 68001015200. Its NADAC has been published 658 times since Feb 26, 2014.
FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001015200
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA077614FDA Approved
9/5/2007
TE Code
AB
On Market Since
4/22/2014
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 25 MG TABLET has been published 658 times since Feb 26, 2014, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0323 per EA |
|---|---|
| All-time high | $0.0422 (Dec 16, 2015) |
| All-time low | $0.0255 (Nov 20, 2024) |
| 52-week high | $0.0323 |
| 52-week low | $0.0312 |
| Median price | $0.0324 |
| Average price | $0.0329 |
| Largest weekly change | +24.5% (Nov 18, 2015) |
| Weeks tracked | 658 |
| Tracking since | Feb 26, 2014 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carvedilol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARVEDILOL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 25 MG TABLET, manufactured by BluePoint Laboratories, is $0.0323 per EA (NDC 68001015200), effective Sep 30, 2026.
How has the price of CARVEDILOL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 25 MG TABLET has declined 11.7%. It has been tracked across 658 weekly CMS publications since Feb 26, 2014.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 25 MG TABLET?
Since Feb 26, 2014, the NADAC for CARVEDILOL 25 MG TABLET has ranged from a low of $0.0255 (Nov 20, 2024) to a high of $0.0422 (Dec 16, 2015), with a median of $0.0324 per EA.
Are there cheaper alternatives to CARVEDILOL 25 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARVEDILOL 25 MG TABLET, is $0.0319 per EA — about 1% below CARVEDILOL 25 MG TABLET.
Who manufactures CARVEDILOL 25 MG TABLET?
CARVEDILOL 25 MG TABLET (NDC 68001015200) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.